Arratia-Maqueo J A, Garza-Cortés R, Gómez-Guerra L S, Cortés-González J R
Servicio de Urología, Hospital Universitario «Dr. José E. González» UANL Monterrey, NL México.
Actas Urol Esp. 2010 Nov;34(10):866-9.
Evaluate the effect of dutasteride in perioperative bleeding during Transurethral Resection of Prostate (TURP).
Forty consecutive patients with criteria for TURP were included. Finasteride/dutasteride use, renal impairment, prostate < 30 cc, age <50 were excluded. Patients were divided in 2 groups. Group 1: 24 consecutive patients treated with dutasteride 0.5 mg/day/30-days prior TURP. Group 2: 16 without treatment. Prostatic volume, difference in hemoglobin pre/post TURP, duration and amount of resected tissue were recorded. Surgeon was blinded.
Multiple linear regression, Mann-Whitney and student t-tests were used.
In group 1, 33% (8) improved their lower urinary tract symptoms and skipped TURP. Mean Hemoglobin loss difference between groups was 0.11 gr/dl (CI 95% -0.55; 0.77, p=0.88). There was no statistical difference among variables. No positive or negative predictive values in the linear regression model.
Dutasteride did not significantly impact the studied variables in these non randomized and small sample size settings.
评估度他雄胺在经尿道前列腺切除术(TURP)围手术期出血中的作用。
纳入40例符合TURP标准的连续患者。排除使用非那雄胺/度他雄胺、肾功能损害、前列腺<30立方厘米、年龄<50岁的患者。患者分为2组。第1组:24例连续患者在TURP前30天每天服用0.5毫克度他雄胺。第2组:16例未接受治疗。记录前列腺体积、TURP前后血红蛋白差异、切除组织的持续时间和数量。外科医生不知情。
采用多元线性回归、曼-惠特尼检验和学生t检验。
在第1组中,33%(8例)改善了下尿路症状并跳过了TURP。两组之间的平均血红蛋白损失差异为0.11克/分升(95%置信区间-0.55;0.77,p=0.88)。各变量之间无统计学差异。线性回归模型中无阳性或阴性预测值。
在这些非随机且小样本量的情况下,度他雄胺对所研究的变量没有显著影响。